相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。c-MET Receptor-Targeted Fluorescence on the Road to Image-Guided Surgery in Penile Squamous Cell Carcinoma Patients
Hielke M. de Vries et al.
JOURNAL OF NUCLEAR MEDICINE (2022)
Crosstalk of the Wnt/β-Catenin Signaling Pathway in the Induction of Apoptosis on Cancer Cells
Cristina Trejo-Solis et al.
PHARMACEUTICALS (2021)
Survivin expression and impact on head and neck cancer outcomes
Saad A. Khan et al.
ORAL ONCOLOGY (2021)
MET inhibitor, capmatinib overcomes osimertinib resistance via suppression of MET/Akt/snail signaling in non-small cell lung cancer and decreased generation of cancer-associated fibroblasts
Kaibin Zhu et al.
AGING-US (2021)
Computational study on novel natural inhibitors targeting c-MET
Yuanyuan Hou et al.
MEDICINE (2021)
Preclinical evaluation of [18F]cabozantinib as a PET imaging agent in a prostate cancer mouse model
Vegard Torp Lien et al.
NUCLEAR MEDICINE AND BIOLOGY (2021)
Penile cancer
Anita Thomas et al.
NATURE REVIEWS DISEASE PRIMERS (2021)
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors
Scott T. Tagawa et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Systemic treatment of penile squamous cell carcinoma-hurdles and hopes of preclinical models and clinical regimens: a narrative review
Anita Thomas et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
Anita Thomas et al.
CANCERS (2021)
Mini-Review: Cabozantinib in the Treatment of Advanced Renal Cell Carcinoma and Hepatocellular Carcinoma
Nityam Rathi et al.
CANCER MANAGEMENT AND RESEARCH (2020)
Off-target based drug repurposing opportunities for tivantinib in acute myeloid leukemia
Brent M. Kuenzi et al.
SCIENTIFIC REPORTS (2019)
Molecular targets for tivantinib (ARQ 197) and vasculogenic mimicry in human melanoma cells
Senthil R. Kumar et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
Pivotal Trial of Enfortumab Vedotin in Urothelial Carcinoma After Platinum and Anti-Programmed Death 1/Programmed Death Ligand 1 Therapy
Jonathan E. Rosenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
β-Catenin Activation Promotes Immune Escape and Resistance to Anti-PD-1 Therapy in Hepatocellular Carcinoma
Marina Ruiz de Galarreta et al.
CANCER DISCOVERY (2019)
Targeted Therapy for Advanced Thyroid Cancer: Kinase Inhibitors and Beyond
Maria E. Cabanillas et al.
ENDOCRINE REVIEWS (2019)
N-Myc mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
Adeline Berger et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
EGFR mono-antibody salvage therapy for locally advanced and distant metastatic penile cancer: Clinical outcomes and genetic analysis
Kang-bo Huang et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2019)
Drug-adapted cancer cell lines as preclinical models of acquired resistance
Martin Michaelis et al.
CANCER DRUG RESISTANCE (2019)
Role of β-catenin in cisplatin resistance, relapse and prognosis of head and neck squamous cell carcinoma
Souvick Roy et al.
CELLULAR ONCOLOGY (2018)
Osimertinib and other third-generation EGFR TKI in EGFR-mutant NSCLC patients
J. Remon et al.
ANNALS OF ONCOLOGY (2018)
The role of peroxisome proliferator-activated receptor gamma in prostate cancer
Catherine Elix et al.
ASIAN JOURNAL OF ANDROLOGY (2018)
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy
Paolo M. Comoglio et al.
NATURE REVIEWS CANCER (2018)
Prognostic value of c-MET in head and neck cancer: A systematic review and meta-analysis of aggregate data
Petr Szturz et al.
ORAL ONCOLOGY (2017)
Treatment of renal cell carcinoma: Current status and future directions
Pedro C. Barata et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Beyond chemotherapy for advanced disease-the role of EGFR and PD-1 inhibitors
Weijie Gu et al.
TRANSLATIONAL ANDROLOGY AND UROLOGY (2017)
C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis
Jing-Li Ren et al.
PANMINERVA MEDICA (2017)
Small molecule inhibitor of c-Met (PHA665752) suppresses the growth of ovarian cancer cells and reverses cisplatin resistance
Enze Li et al.
TUMOR BIOLOGY (2016)
Squamous Cell Cancers: A Unified Perspective on Biology and Genetics
G. Paolo Dotto et al.
CANCER CELL (2016)
Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database Analysis
Brian R. Winters et al.
UROLOGY (2016)
The role of histologic subtype, p16INK4a expression, and presence of human papillomavirus DNA in penile squamous cell carcinoma
Julie Steinestel et al.
BMC CANCER (2015)
Epidemiology of penile cancer
Michelle Christodoulidou et al.
CURRENT PROBLEMS IN CANCER (2015)
PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation
Y. Liu et al.
ONCOGENE (2015)
The epidermal growth factor receptors as biological targets in penile cancer
Giuseppe Di Lorenzo et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2015)
GSK3 Alpha and Beta Are New Functionally Relevant Targets of Tivantinib in Lung Cancer Cells
Lily L. Remsing Rix et al.
ACS CHEMICAL BIOLOGY (2014)
The expression of C-FABP and PPAR gamma and their prognostic significance in prostate cancer
Farzad S. Forootan et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2014)
The Role of Snail in EMT and Tumorigenesis
Yifan Wang et al.
CURRENT CANCER DRUG TARGETS (2013)
C-MET is expressed in the-majority of penile squamous cell carcinomas and correlates with polysomy-7 but is not associated with MET oncogene amplification, pertinent histopathologic parameters, or with cancer-specific survival
Sven Gunia et al.
PATHOLOGY RESEARCH AND PRACTICE (2013)
Survivin as a Prognostic/Predictive Marker and Molecular Target in Cancer Therapy
F. Roedel et al.
CURRENT MEDICINAL CHEMISTRY (2012)
Neoadjuvant Paclitaxel, Ifosfamide, and Cisplatin Chemotherapy for Metastatic Penile Cancer: A Phase II Study
Lance C. Pagliaro et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
ARQ 197, a Novel and Selective Inhibitor of the Human c-Met Receptor Tyrosine Kinase with Antitumor Activity
Neru Munshi et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Developing c-MET pathway inhibitors for cancer therapy: progress and challenges
Xiangdong Liu et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Aberrant β-catenin expression in the histologic differentiation of oral squamous cell carcinoma and verrucous carcinoma: an immunohistochemical study
Lankesh B. Laxmidevi et al.
Journal of Oral Science (2010)
Novel Therapeutic Inhibitors of the c-Met Signaling Pathway in Cancer
Joseph Paul Eder et al.
CLINICAL CANCER RESEARCH (2009)
The Activated NF-kappa B-Snail-RKIP Circuitry in Cancer Regulates Both the Metastatic Cascade and Resistance to Apoptosis by Cytotoxic Drugs
Katherine Wu et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: A preclinical model
R Kotchetkov et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
分享论文
